Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$115,739,498
+$38,176,841 QoQ
Shares Held
6,185,970
-20.6% QoQ
Ownership
2.82%
of shares outstanding
% of Portfolio
2.51%
of 13F equity value
Holder Rank
#11
of 254 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bellevue Group AG holds $2,744,593,561 across 63 Biotechnology names. RLAY ranks #8 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
578,634 | $287,424,866 | |
| 2 | ARGX |
Argenx SE
|
301,000 | $279,258,770 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,048,014 | $196,272,061 | |
| 4 | ORKA |
Oruka Therapeutics, Inc.
|
1,657,190 | $157,714,772 | |
| 5 | INSM |
INSMED Inc
|
1,393,418 | $148,566,226 | |
| 6 | SRRK |
Scholar Rock Holding Corp
|
2,449,547 | $134,725,085 | |
| 7 | VRDN |
Viridian Therapeutics, Inc.\DE
|
6,731,909 | $123,665,167 | |
| 8 | RLAY |
Relay Therapeutics, Inc.
This page
|
6,185,970 | $115,739,498 |
All Filings in RLAY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115,739,498 | 6,185,970 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $77,562,657 | 7,795,242 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $70,601,779 | 8,345,364 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $43,564,083 | 8,345,610 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $28,478,809 | 8,230,870 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $19,328,505 | 7,377,292 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $30,394,443 | 7,377,292 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $52,230,462 | 7,377,184 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $41,578,789 | 6,377,115 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $49,190,929 | 5,926,618 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $65,356,262 | 5,936,082 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $41,082,850 | 4,885,000 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $52,385,248 | 4,170,800 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $68,722,722 | 4,172,600 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $62,820,010 | 4,204,820 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $94,061,823 | 4,204,820 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $67,540,388 | 4,032,262 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $117,294,532 | 3,918,962 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $126,094,093 | 4,105,962 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $118,425,481 | 3,755,962 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $96,632,799 | 2,640,962 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $66,766,562 | 1,931,344 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $58,572,876 | 1,409,357 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $55,367,000 | 1,300,000 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||